Vikram B. Wali

1.8k total citations
41 papers, 1.3k citations indexed

About

Vikram B. Wali is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Vikram B. Wali has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cancer Research, 20 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Vikram B. Wali's work include Cancer Genomics and Diagnostics (13 papers), BRCA gene mutations in cancer (5 papers) and Cancer-related Molecular Pathways (5 papers). Vikram B. Wali is often cited by papers focused on Cancer Genomics and Diagnostics (13 papers), BRCA gene mutations in cancer (5 papers) and Cancer-related Molecular Pathways (5 papers). Vikram B. Wali collaborates with scholars based in United States, Hungary and Germany. Vikram B. Wali's co-authors include Paul W. Sylvester, Sunitha V. Bachawal, Lajos Pusztai, Christos Hatzis, Gauri A. Patwardhan, David L. Rimm, Khalid A. El Sayed, Vasiliki Pelekanou, Veerle Bossuyt and Qin Yan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Vikram B. Wali

40 papers receiving 1.3k citations

Peers

Countries citing papers authored by Vikram B. Wali

Since Specialization

Citations

This map shows the geographic impact of Vikram B. Wali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikram B. Wali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikram B. Wali more than expected).

Fields of papers citing papers by Vikram B. Wali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikram B. Wali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikram B. Wali. The network helps show where Vikram B. Wali may publish in the future.

Co-authorship network of co-authors of Vikram B. Wali

This figure shows the co-authorship network connecting the top 25 collaborators of Vikram B. Wali. A scholar is included among the top collaborators of Vikram B. Wali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikram B. Wali. Vikram B. Wali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Analysis of Pre- and Posttreatment Tissues from the SWOG S0800 Trial Reveals an Effect of Neoadjuvant Chemotherapy on the Breast Cancer Genome 2020 ·Clinical Cancer Research ·Ryan L. Powles, Vikram B. Wali, Xiaotong Li, William E. Barlow, Zeina Nahleh, Alastair M. Thompson, Andrew K. Godwin, Christos Hatzis, Lajos Pusztai	9
2	Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells 2020 ·Cancers ·Michał Marczyk, Gauri A. Patwardhan, Jun Zhao, Rihao Qu, Xiaotong Li, Vikram B. Wali, Abhishek Gupta, Manoj M. Pillai, Yuval Kluger, Qin Yan, Christos Hatzis, Lajos Pusztai, Vignesh Gunasekharan	15
3	Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer 2019 ·Scientific Reports ·Vikram B. Wali, Gauri A. Patwardhan, Vasiliki Pelekanou, Thomas Karn, Jian Cao, Alberto Ocaña, Qin Yan, Bryce Nelson, Christos Hatzis, Lajos Pusztai	18
4	Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trial 2019 ·Journal for ImmunoTherapy of Cancer ·Xiaotong Li, Sarah Warren, Vasiliki Pelekanou, Vikram B. Wali, Alessandra Cesano, Mingdong Liu, Patrick Danaher, (unknown), Zeina Nahleh, Daniel F. Hayes, Gabriel N. Hortobágyi, William E. Barlow, Christos Hatzis, Lajos Pusztai	46
5	Immunological differences between primary and metastatic breast cancer 2018 ·Annals of Oncology ·Borbála Székely, Veerle Bossuyt, Xiaofeng Li, Vikram B. Wali, Gauri A. Patwardhan, (unknown), Andrea Silber, (unknown), Malini Harigopal, Vasiliki Pelekanou, Ming Zhang, Qin Yan, David L. Rimm, Giampaolo Bianchini, Christos Hatzis, Lajos Pusztai	240
6	Increased epigenetic age in normal breast tissue from luminal breast cancer patients 2018 ·Clinical Epigenetics ·Erin Hofstatter, Steve Horvath, D. Dalela, (unknown), Anees B. Chagpar, Vikram B. Wali, Veerle Bossuyt, Anna Maria Storniolo, Christos Hatzis, Gauri A. Patwardhan, (unknown), Meghan Butler, (unknown), Karen Stavris, (unknown), Alexander Au, Stephanie Kwei, Lajos Pusztai	37
7	Reliability of Whole-Exome Sequencing for Assessing Intratumor Genetic Heterogeneity 2018 ·Cell Reports ·Weiwei Shi, Charlotte K.Y. Ng, Raymond S. Lim, Tingting Jiang, Sushant Kumar, Xiaotong Li, Vikram B. Wali, Salvatore Piscuoglio, Mark Gerstein, Anees B. Chagpar, Britta Weigelt, Lajos Pusztai, Jorge S. Reis‐Filho, Christos Hatzis	59
8	Systematic Drug Screening Identifies Tractable Targeted Combination Therapies in Triple-Negative Breast Cancer 2016 ·Cancer Research ·Vikram B. Wali, Casey G. Langdon, Matthew A. Held, James T. Platt, Gauri A. Patwardhan, Anton Safonov, Bilge Aktaş, Lajos Pusztai, David F. Stern, Christos Hatzis	38
9	Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast Cancer 2016 ·Clinical Cancer Research ·(unknown), Kirsten M. Timms, Anees B. Chagpar, Vikram B. Wali, Tingting Jiang, Veerle Bossuyt, Ozlen Saglam, Julia Reid, Alexander Gutin, Chris Neff, Jerry S. Lanchbury, Christos Hatzis, Erin Hofstatter, Lajos Pusztai	26
10	Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis 2016 ·PLoS Medicine ·Tingting Jiang, Weiwei Shi, Vikram B. Wali, Lőrinc Sándor Pongor, Charles H. Li, Rosanna Lau, Balázs Győrffy, Richard P. Lifton, W. Fraser Symmans, Lajos Pusztai, Christos Hatzis	57
11	miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer 2015 ·Cancer Research ·Brian D. Adams, Vikram B. Wali, Christopher J. Cheng, Sachi Inukai, Carmen J. Booth, Seema Agarwal, David L. Rimm, Balázs Győrffy, Libero Santarpia, Lajos Pusztai, W. Mark Saltzman, Frank J. Slack	128
12	Characterization of DNA variants in the human kinome in breast cancer 2015 ·Scientific Reports ·Divyansh Agarwal, Yuan Qi, Tingting Jiang, Xiuping Liu, Weiwei Shi, Vikram B. Wali, Benjamin E. Turk, Jeffrey S. Ross, W. Fraser Symmans, Lajos Pusztai, Christos Hatzis	2
13	Convergent and Divergent Cellular Responses by ErbB4 Isoforms in Mammary Epithelial Cells 2014 ·Molecular Cancer Research ·Vikram B. Wali, Jonathan W. Haskins, Maureen Gilmore-Hebert, James T. Platt, Zongzhi Liu, David F. Stern	20
14	Metabolic isoenzyme shifts in cancer as potential novel therapeutic targets 2014 ·Breast Cancer Research and Treatment ·(unknown), Wenhao Shi, Vikram B. Wali, (unknown), Tingting Jiang, Christos Hatzis, Lajos Pusztai	5
15	Global gene expression changes induced by prolonged cold ischemic stress and preservation method of breast cancer tissue 2014 ·Molecular Oncology ·Bilge Aktaş, Hongxia Sun, Hui Yao, Weiwei Shi, (unknown), Ya Zhang, Tingting Jiang, (unknown), Vikram B. Wali, Lajos Pusztai, W. Fraser Symmans, Christos Hatzis	17
16	Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis 2014 ·Breast Cancer Research ·Vikram B. Wali, Maureen Gilmore-Hebert, Ramanaiah Mamillapalli, Jonathan W. Haskins, Kari J. Kurppa, Klaus Elenius, Carmen J. Booth, David F. Stern	24
17	Enhanced antiproliferative and apoptotic response to combined treatment of γ-tocotrienol with erlotinib or gefitinib in mammary tumor cells 2010 ·BMC Cancer ·Sunitha V. Bachawal, Vikram B. Wali, Paul W. Sylvester	47
18	Redox-silent tocotrienol esters as breast cancer proliferation and migration inhibitors 2010 ·Bioorganic & Medicinal Chemistry ·Fathy A. Behery, Ahmed Y. Elnagar, Mohamed R. Akl, Vikram B. Wali, Bilal Abuasal, Amal Kaddoumi, Paul W. Sylvester, Khalid A. El Sayed	21
19	Design and preliminary structure–activity relationship of redox-silent semisynthetic tocotrienol analogues as inhibitors for breast cancer proliferation and invasion 2009 ·Bioorganic & Medicinal Chemistry ·Ahmed Y. Elnagar, Vikram B. Wali, Paul W. Sylvester, Khalid A. El Sayed	16
20	Anti‐proliferative effects of γ‐tocotrienol on mammary tumour cells are associated with suppression of cell cycle progression 2009 ·Cell Proliferation ·Ganesh V. Samant, Vikram B. Wali, Paul W. Sylvester	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact